| n | Total T2DM | T2DM + CKDb | T2DM − CKDb | p-value |
---|---|---|---|---|---|
(n = 343,675) | (n = 171,930) | (n = 171,745) | |||
Healthcare provider | |||||
 Office based in % | 343,675 | 35.9 | 31.5 | 40.3 | < 0.001 |
 Hospital based in % | 343,675 | 64.1 | 68.5 | 59.7 | < 0.001 |
Age in years | 343,675 | 70.3 (60.4; 78.0) | 74.5 (66.2;80.7) | 65.5 (56.2; 74.1) | < 0.001 |
Female gender in % | 343,675 | 47.2 | 52.4 | 42.0 | < 0.001 |
Weight in kg | 321,929 | 85.5 (74.0; 100.0) | 84.7 (73.0; 98.3) | 87.0 (75.0; 101.0) | < 0.001 |
Body mass index in kg/m2 | 314,804 | 29.9 (26.3; 34.4) | 29.9 (26.3; 34.4) | 29.9 (26.4; 34.4) | 0.027 |
Blood pressure | |||||
 Systolic BP in mmHg | 330,285 | 132.5 (121.0; 145.0) | 132.5 (120.0; 145.0) | 132.5 (122.0; 144.0) | 0.007 |
  Systolic BP ≥ 140 mmHg in % | 330,285 | 41.5 | 41.7 | 41.4 | < 0.001 |
 Diastolic BP in mmHg | 329,769 | 80.0 (70.0; 81.0) | 78.0 (70.0; 80.0) | 80.0 (70.0; 83.0) | < 0.001 |
  Diastolic BP ≥ 90 mmHg in % | 329,769 | 14.0 | 12.2 | 15.9 | < 0.001 |
 AntiHT drug treatment in % | 343,675 | 56.7 | 62.6 | 20.7 | < 0.001 |
 Hypertensiona in % | 335,762 | 75.7 | 79.4 | 72.0 | < 0.001 |
Dyslipidemia | 285,009 | 87.4 | 88.4 | 86.3 | < 0.001 |
 LDL-C in mg/dL | 236,106 | 108.3 (83.0, 137.0) | 105.0 (79.3; 135.0) | 112.1 (86.8; 139.2) | < 0.001 |
 TC in mg/dL | 263,462 | 185.6 (154.7; 218.5) | 181.8 (150.8; 216.0) | 189.0 (159.0; 220.4) | < 0.001 |
 TG in mg/dL | 254,288 | 155.0 (110.0; 223.7) | 157.9 (113.0; 228.1) | 151.0 (107.0; 219.3) | < 0.001 |
 HDL-C in men in mg/dL | 128,099 | 41.0 (34.0; 50.0) | 40.0 (33.0; 48.5) | 42.0 (34.8; 50.3) | < 0.001 |
 HDL-C in women in mg/dL | 110,834 | 46.4 (37.5; 58.0) | 46.4 (37.5; 57.0) | 50.0 (41.0; 60.0) | < 0.001 |
Diabetes | |||||
 Diabetes duration in years | 343,675 | 9.0 (3.5, 15.4) | 10.3 (4.9; 17.2) | 7.2 (2.4; 13.4) | < 0.001 |
  0–5 years in % | 343,675 | 32.3 | 25.5 | 39.1 | < 0.001 |
  6–10 years in % | 343,675 | 22.7 | 22.2 | 23.2 | < 0.001 |
  > 10 years in % | 343,675 | 45.0 | 52.3 | 37.8 | < 0.001 |
 HbA1c in % | 325,058 | 7.1 (6.3; 8.4) | 7.2 (6.3; 8.3) | 7.1 (6.3; 8.4) | < 0.001 |
  HbA1c < 6.5% | 325,058 | 31.6 | 30.5 | 32.7 | < 0.001 |
  HbA1c < 7.0% | 325,058 | 46.5 | 45.8 | 47.3 | < 0.001 |
Kidney parameters | |||||
 Potassium | |||||
  ≤ 4.8 mmol/L in % | 73,615 | 85.4 | 81.8 | 89.8 | < 0.001 |
  > 4.8– ≤ 5.5 mmol/L in % | 73,615 | 12.2 | 14.6 | 9.3 | < 0.001 |
  > 5.5– ≤ 6.0 mmol/L in % | 73,615 | 1.6 | 2.4 | 0.7 | < 0.001 |
  > 6.0 mmol/L in % | 73,615 | 0.8 | 1.3 | 0.3 | < 0.001 |
 Urinary albumin in mg/g | |||||
  Normal (< 30 mg/g) in % | 240,510 | 71.9 | 48.8 | 100.0 | < 0.0001 |
  Micro (≥ 30–300 mg/g) in % | 240,510 | 22.5 | 40.8 | 0.0 | < 0.001 |
  Macro (> 300 mg/g) in % | 204,211 | 5.6 | 10.4 | 0.0 | < 0.001 |
 Creatinine in mg/dL | 343,513 | 1.0 (0.8; 1.3) | 1.3 (1.0; 1.6) | 0.8 (0.7; 1.0) | < 0.001 |
 eGFR mL/min/1.73 m2 | 343,675 | 67.9 (48.9; 85.9) | 48.9 (36.3; 59.0) | 81.6 (71.0; 96.5) | < 0.001 |
  < 15 | 343,675 | 1.5 | 3.0 | 0.0 | < 0.001 |
  15 to < 30 in % | 343,675 | 6.3 | 12.6 | 0.0 | < 0.001 |
  30 to < 45 in % | 343,675 | 13.0 | 25.9 | 0.0 | < 0.001 |
  45 to < 60 in % | 343,675 | 18.3 | 36.6 | 0.0 | < 0.001 |
  60 to < 89 in % | 343,675 | 40.2 | 14.1 | 66.3 | < 0.001 |
  ≥ 90 in % | 343,675 | 20.8 | 7.9 | 33.7 | < 0.001 |